glp-1 market news november 2025 Receptor Agonist Size & Analysis, 2026-2033 GLP-1 Agonists Market Report 2025-2033,

EXPERTS ARE SPLIT ON RISKS VS BENEFITS University of Pennsylvania researchers used artificial intelligence to analyze more than five years of Reddit posts from more than 67,000 people taking the popular drugs for diabetes or weight loss

Owing to its potential benefits in treating diabetes and off-label use for obese conditions, the molecule will bring cumulative sales of more than USD 100 billion by 2029

And it pairs with virtually any flavor profile

Meanwhile, we should realize that the current research mostly emphasizes the correlation between gut microbiota dysbiosis and disease, as well as disease outcome and gut microbiota alterations, which is far from sufficient

Yuan Z, Li D, Feng P, Xue G, Ji C, Li G, et al